RANITIDINE FOR DUODENAL-ULCER - COMPARISON OF ONE-DOSE AND 2-DOSE ADMINISTRATION

Authors:
  • WAW AENISHANSLIN
    W AENISHANSLIN
  • RBR BERGOZ
    R BERGOZ
  • YCY CAPITAINE
    Y CAPITAINE
  • GEG EGGER
    G EGGER
  • AEA ETIENNE
    A ETIENNE
  • IFI FUMAGALLI
    I FUMAGALLI
  • RGR GULLER
    R GULLER
  • BHB HAMMER
    B HAMMER
  • EKE KOBLER
    E KOBLER
  • ELE LEUTHOLD
    E LEUTHOLD
  • WMW MATTLE
    W MATTLE
  • FMFD MEYER
    FD MEYER

  • 10 May 1986
    • journal article
    • research article
    • Vol. 116  (19) , 637-641
    • PMID:3715441
Abstract
In a Swiss multicenter double-blind trial ranitidine was given in doses of 300 mg nocte and 150 mg b.d. for the treatment of duodenal ulcer. Ninety-seven patients with endoscopically proven ulcer were treated for four, and in cases of non-healing for eight weeks. Cumulative healing rates with 300 mg and 2 .times. 150 mg were 77% and 78% after four weeks and 90% and 94% after eight weeks, respectively. Sixty and 65% of the patients were asymptomatic after four weeks. Smoking did not adversely affect healing. Thus, ranitidine in a dose of 300 mg nocte is as effective as ranitidine in a dose of 150 mg b.d. in the treatment of duodenal ulcer.

This publication has 12 references indexed in Scilit: